title: Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.
authors.affiliation: Laboratoire de Pharmacologie Médicale et Clinique de la Faculté de Médecine, UMR-INSERM U 1027 Equipe de Pharmacoépidémiologie, Université de Toulouse, France. montastruc@cict.fr
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Montastruc
authors.forename: Agnès
authors.initials: A
authors.lastname: Sommet
authors.forename: Haleh
authors.initials: H
authors.lastname: Bagheri
authors.forename: Maryse
authors.initials: M
authors.lastname: Lapeyre-Mestre
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000139:chemically induced*